Previous Page  5 / 14 Next Page
Information
Show Menu
Previous Page 5 / 14 Next Page
Page Background

allied

academies

Page 17

Note:

International Journal of Respiratory Medicine

|

Volume 3

LUNG CANCER AND COPD

5

th

International Congress on

J u n e 2 5 - 2 6 , 2 0 1 8 | A m s t e r d a m , N e t h e r l a n d s

Laetitia Seguin et al., Int J Respir Med 2018, Volume 3

GALECTIN-3, A DRUGGABLE

VULNERABILITY FOR KRAS-ADDICTED

CANCERS

Laetitia Seguin, Camargo MF, Wettersten H, Kato S

Desgrosellier JS, Von Schalscha T, Elliott KC, Cosset E

Lesperance J, Weis SM

and

Cheresh DA

IRCAN, France

I

dentifying the molecular basis for cancer cell dependence on oncogenes

such as KRAS can provide new opportunities to target these addictions.

Here, we identify a novel role for the carbohydrate-binding protein galectin-3

as a lynchpin for KRAS dependence. By directly binding to the cell surface

receptor integrin αvβ3, galectin-3 gives rise to KRAS addiction by enabling

multiple functions of KRAS in anchorage-independent cells, including

formation of macropinosomes that facilitate nutrient uptake and ability to

maintain redox balance. Disrupting αvβ3/galectin-3 binding with a clinically

active drug prevents their association withmutant KRAS, thereby suppression

macropinocytosis while increasing reactive oxygen species to eradicate

αvβ3-expressing KRAS-mutant lung and pancreatic cancer patient-derived

xenografts and spontaneous tumors in mice. Our work reveals galectin-3 as a

druggable target for KRAS-addicted lung and pancreas cancers and indicates

integrin αvβ3 as a biomarker to identify susceptible tumors. There is a

significant unmet need for therapies targeting KRAS-mutant cancers. Here,

we identify integrin αvβ3 as a biomarker to identify mutant KRAS-addicted

tumors that are highly sensitive to inhibition of galectin-3, a glycoprotein that

binds to integrin αvβ3 to promote KRAS-mediated activation of AKT.

Laetitia Seguin is currently working as a post-

doctoral fellow in C Feral Laboratory Epithelial

homeostasis and tumorigenesis at IRCAN,

France. She has published many papers in the

reputed journals with the eminent authors. She

has a great publication in the peer reviewed con-

ference proceedings also.

Laetitia.Seguin@unice.fr

BIOGRAPHY